News 
Market Data 
Discover
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
OSIR buy 5.720
bull flag
inverted head and shoulders bottom
bullish divergence
support at moving averages
previous high volume indicates the bottom and major support
because most of all the potential sellers are now exhausted and out
price now beginning a nascent uptrend above the ichimoku span clouds
normal chart
log chart
OSIR bullish 2.80
normal chart
log chart
OSIR
where to next? maybe slight pullback to accumulate?
R5
OSIR
where to next? maybe slight pullback to accumulate?
R5
OSIR
running under the radar screen im guessing.
R5
OSIR
hate gaps up but whatta we gonna do, didnt get as many as i wanted
but happy for now.
Happy Coding
R5
OSIR- News
small trades after hours at $5.77 tomorrow should be interesting
R5
OSIR
Osiris actually headed up to some important pivot points and resistance zones on strength, with about 17% of the float shorted and a short ratio of 32.29, this could turn into a short squeeze fast should it keep trickling up. I'll be watching the action and dabbling for a few more just in case, Ill be cautious where to set a trailing stop just in case, these algorithms are a bitch sometimes to figure out. more later. trade well
Happy coding
R5
OSIR
dead duck bounce
R5
OSIR
been stalking this for sometime, starting to look ready to go up
started a small position and will build going up should that happen,
Biotechs seem to be staying strong for now.
R5
|
Followers
|
29
|
Posters
|
|
|
Posts (Today)
|
0
|
Posts (Total)
|
268
|
|
Created
|
08/28/07
|
Type
|
Free
|
| Moderators | |||
Osiris Therapeutics, Inc (OSIR)
Company Address:
7015 Albert Einstein Drive
Columbia, MD 21046
Phone: 443.545.1800
Fax: 443.545.1701
Directions Map
E-mail: Osiris@Osiris.com
CIK: 0001360886
Osiris Therapeutics, Inc. is a leading stem cell company focused on developing and marketing products to treat medical conditions in the inflammatory, autoimmune, orthopedic and cardiovascular areas. Osiris' stem cell products have significant therapeutic potential because of their ability to regulate inflammation, promote tissue regeneration and prevent pathological scar formation.
Management:
C. Randal Mills, Ph.D., President and Chief Executive Officer
Philip R. Jacoby, Jr., Chief Financial Officer and Corporate Secretary
Michelle LeRoux Williams, Ph.D., Chief Scientific Officer
Lode Debrabandere, Ph.D., Senior Vice President, Therapeutics
Stephen W. Potter, Senior Vice President of Operations and Corporate Development
Douglas Jacobstein, M.D., Senior Director, Medical Affairs
Christopher R. Alder, J.D., Chief Intellectual Property Counsel
Important Company Highlights:
|
Prochymal is being evaluated in Phase 3 clinical trials for several indications, including acute graft versus host disease (GvHD) and also Crohn's disease, and is the only stem cell therapeutic currently designated by the FDA as both an Orphan Drug and Fast Track product. |
| Prochymal is also being developed for the repair of heart tissue following a heart attack, the protection of pancreatic islet cells in patients with type 1 diabetes, and the repair of lung tissue in patients with pulmonary disease. |
| Osiris has partnered with Genzyme Corporation to develop Prochymal as a medical countermeasure to nuclear terrorism and other radiological emergencies. |
Chondrogen is currently being evaluated in clinical trials for the treatment of osteoarthritis in the knee. Enrollment for this trial has been completed.
Recent News:
http://finance.yahoo.com/q/h?s=ODP+Headlines
Transfer Agent:
Stocktrans, Inc.
44 W Lancaster Ave
Ardmore, PA 19003
610.649.7300
Share Structure:
Outstanding Shares
32,790,019 as of Nov 4, 2010
Authorized Shares
90,000,000 as of Sept 30, 2010
Investor Relations:
Erica Elchin
Phone: 443.545.1834
E-mail: OsirisPR@Osiris.com
All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
Also, keep in mind that moderators may or may not have a position in said stock. Being a moderator isn't a sign of endorsement.
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp
